Anticov Biotech

安谛康生物

Anticov Biotech

Biotech/Healthcare

Anticancer Bioscience has developed a pipeline of innovative drugs that includes a single-dose treatment for influenza, an oral treatment for COVID-19, therapies targeting RSV and other respiratory viruses, and a potential cure for endometriosis. Its oral COVID-19 drug CN-2021 is scheduled to enter…

Latest round: Pre Series A (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-04-01